NCT06606756 CEDATA GPGE - a Patient Registry for Children and Adolescents With Inflammatory Bowel Disease
| NCT ID | NCT06606756 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Giessen |
| Condition | Inflammatory Bowel Disease (IBD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,300 participants |
| Start Date | 2004-09-01 |
| Primary Completion | 2034-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,300 participants in total. It began in 2004-09-01 with a primary completion date of 2034-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CEDATA GPGE collects clinical data of children and adolescents with IBD from paediatric gastroenterology centers in german-speaking countries. Data is obtained from participating centers in pseudonymized way via an online platform at the beginning and during followup of the disease. The leading working group of the paediatric gastroenterology society GPGE e.V. includes 15 experts in the field who meet twice yearly and coordinate research and quality improvement initiatives.
Eligibility Criteria
Inclusion Criteria: * Inflammatory Bowel Disease Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06606756 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Inflammatory Bowel Disease (IBD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06606756 currently recruiting?
Yes, NCT06606756 is actively recruiting participants. Contact the research team at jan.delaffolie@paediat.med.uni-giessen.de for enrollment information.
Where is the NCT06606756 trial being conducted?
This trial is being conducted at Giessen, Germany.
Who is sponsoring the NCT06606756 clinical trial?
NCT06606756 is sponsored by University of Giessen. The trial plans to enroll 6,300 participants.